- Home
- BDL vs OSTX Comparison
BDL vs OSTX Comparison
Compare BDL & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDL
- OSTX
- Stock Information
- Founded
- BDL 1959
- OSTX 2018
- Country
- BDL United States
- OSTX United States
- Employees
- BDL N/A
- OSTX N/A
- Industry
- BDL Restaurants
- OSTX
- Sector
- BDL Consumer Discretionary
- OSTX
- Exchange
- BDL Nasdaq
- OSTX NYSE
- Market Cap
- BDL 44.1M
- OSTX 45.0M
- IPO Year
- BDL N/A
- OSTX 2024
- Fundamental
- Price
- BDL $31.40
- OSTX $1.63
- Analyst Decision
- BDL
- OSTX Strong Buy
- Analyst Count
- BDL 0
- OSTX 3
- Target Price
- BDL N/A
- OSTX $18.00
- AVG Volume (30 Days)
- BDL 4.1K
- OSTX 239.4K
- Earning Date
- BDL 05-19-2025
- OSTX 05-16-2025
- Dividend Yield
- BDL 3.29%
- OSTX N/A
- EPS Growth
- BDL 14.76
- OSTX N/A
- EPS
- BDL 2.18
- OSTX N/A
- Revenue
- BDL $198,785,000.00
- OSTX N/A
- Revenue This Year
- BDL N/A
- OSTX N/A
- Revenue Next Year
- BDL N/A
- OSTX N/A
- P/E Ratio
- BDL $13.73
- OSTX N/A
- Revenue Growth
- BDL 9.31
- OSTX N/A
- 52 Week Low
- BDL $22.61
- OSTX $1.12
- 52 Week High
- BDL $32.99
- OSTX $7.00
- Technical
- Relative Strength Index (RSI)
- BDL 77.82
- OSTX N/A
- Support Level
- BDL $26.51
- OSTX N/A
- Resistance Level
- BDL $28.50
- OSTX N/A
- Average True Range (ATR)
- BDL 1.11
- OSTX 0.00
- MACD
- BDL 0.51
- OSTX 0.00
- Stochastic Oscillator
- BDL 98.88
- OSTX 0.00
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.